The outbreak of a pandemic
influenza H1N1 in 2009 required the rapid generation of high-yielding
vaccines against the A/California/7/2009 virus, which were achieved by either addition or deletion of a glycosylation site in the
influenza proteins hemagglutinin and
neuraminidase. In this report, we have systematically evaluated the
glycan composition, structural distribution and topology of glycosylation for two high-yield candidate reassortant
vaccines (NIBRG-121xp and NYMC-X181A) by combining various enzymatic digestions with high performance liquid chromatography and multiple-stage mass spectrometry. Proteomic data analyses of the full-length
protein sequences determined 9 N-glycosylation sites of
hemagglutinin, and defined 6 N-glycosylation sites and the
glycan structures of low abundance
neuraminidase, which were occupied by high-
mannose, hybrid and complex-type N-
glycans. A total of ~300
glycopeptides were analyzed and manually validated by tandem mass spectrometry. The specific N-
glycan structure and topological location of these N-
glycans are highly correlated to the spatial
protein structure and the residential
ligand binding. Interestingly, sulfation, fucosylation and bisecting
N-acetylglucosamine of N-
glycans were also reliably identified at the specific glycosylation sites of the two
influenza proteins that may serve a crucial role in regulating the
protein structure and increasing the
protein abundance of the influenza virus reassortants.